EA1-associated KCNA1 mutations differentially increase neurotransmitter release and alter neuronal excitability, providing mechanistic insights into the disease's phenotypic variability.
No takes yet. Share an insight, caveat, or question.
Mutation-specific effects in EA1 models may explain phenotypic variability; leaves open human translation and targeted therapies.
Heeroma et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: